Nandrolone Decanoate (American Regent, Inc.)


Welcome to the PulseAid listing for the Nandrolone Decanoate drug offered from American Regent, Inc.. This Androgen [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Nandrolone Decanoate
SUBSTANCE NAME: NANDROLONE DECANOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen [EPC]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2000-01-01
END MARKETING DATE: 0000-00-00


Nandrolone Decanoate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNandrolone Decanoate from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 200(mg/mL)
START MARKETING DATE: 2000-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-0790_a5bf7ff6-bba0-4e86-92d1-9f929fd4794b
PRODUCT NDC: 0517-0790
APPLICATION NUMBER: ANDA091252

Other NANDROLONE DECANOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Nandrolone Decanoate